How a retracted UK Covid-19 vaccine study tainted the global hunt for mutation-proof shots
A 2022 study exploring a vaccine design for pan-Sars-CoV-2 immunity was retracted last month after its lead author, then in Britain, admitted to fabricating data and falsifying images in the paper. While the retraction of the study, widely cited up until this year by international scientists, marks a significant blow to vaccine research, virologists said the foundational science targeting broader…
Continue reading this story on South China Morning Post, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.